Hereditary AngioedemaSymptoms, Doctors, Treatments, Advances & More
Learn About Hereditary Angioedema
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Allergy Asthma Immunology Associates
Michael Manning is an Allergy and Immunologist practicing medicine in Scottsdale, Arizona. Dr. Manning is rated as an Elite provider by MediFind in the treatment of Hereditary Angioedema. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Angioedema, Hives, Hereditary Angioedema, and Common Variable Immune Deficiency. Dr. Manning is board certified in American Board Of Allergy And Immunology. Dr. Manning is currently accepting new patients.
Raffi Tachdjian is an Allergy and Immunologist practicing medicine in Santa Monica, California. Dr. Tachdjian is rated as an Elite provider by MediFind in the treatment of Hereditary Angioedema. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Angioedema, Hereditary Angioedema, Hives, and Chronic Spontaneous Urticaria (CSU). Dr. Tachdjian is currently accepting new patients.
Asthma And Allergy Associates PC
Daniel Soteres is an Allergy and Immunologist practicing medicine in Colorado Springs, Colorado. Dr. Soteres is rated as an Elite provider by MediFind in the treatment of Hereditary Angioedema. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Angioedema, Hereditary Angioedema, Hives, and Sinusitis. Dr. Soteres is board certified in American Board Of Allergy And Immunology. Dr. Soteres is currently accepting new patients.
Summary: This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent participants with type 1 or type 2 hereditary angioedema (HAE). The goal of this clinical trial is to evaluate the efficacy and safety of navenibart compared to placebo in preventing HAE attacks in partici...
Summary: The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of donidalorsen in pediatric participants with hereditary angioedema (HAE) Type I (HAE-1) or Type II (HAE-2).